Sandoz is Recalling Losartan, a Blood Pressure Medication, due to NDEA Contamination
According to The United States Food and Drug Administration (FDA) media release on 8th Nov, 2018, Sandoz Inc. is voluntarily recalling one lot of Losartan Potassium Hydrochlorothiazide Tablets (USP…
